NEW YORK (GenomeWeb News) - A federal jury late last week awarded Innogenetics $7 million in damages after unanimously finding Abbott Laboratores guilty of willfully infringing an Innogenetics patent covering a method of genotyping the hepatitis C virus.

 

The judge in the case can increase the award to up to three times the $7 million determined by the jury, Innogenetics said, because Abbott was found to have willfully infringed.

 

The jury decided the case in favor of Innogenetics earlier in the month.